Rhiannon Grant
Rhiannon Grant
Contact
Email
show email address
Dr Rhiannon Grant is an early career postdoctoral researcher in the Population Allergy group at MCRI, where she investigates the development of food allergies in early life. She completed her PhD in immunology at Monash University in 2025, examining the molecular mechanisms of an emerging therapy for allergic disease using in vitro models of asthma and atopic dermatitis.
Dr Grant's current research focuses on systemic changes across the first year of life in infants with food allergy within the Vitality Trial, with the aim of identifying predictive biomarkers of food allergy and potential targets for early intervention. She is the recipient of an MCRI Population Health Theme Funding Grant (2025).
Dr Grant's research is informed by lived experience of allergic disease, with the goal of understanding the factors that shape food allergy development in order to improve prevention and intervention strategies in early life. She serves as a peer mentor for Allergy250K, a support program run by the National Allergy Council, where she supports school-aged children and young people living with severe allergies. Dr Grant has also contributed as a lived experience advocate in national roundtable discussions on improving the transition of patients from paediatric to adult allergy care in Australia, and in the development of national guidelines for food allergy management in the food service sector.
Dr Grant's current research focuses on systemic changes across the first year of life in infants with food allergy within the Vitality Trial, with the aim of identifying predictive biomarkers of food allergy and potential targets for early intervention. She is the recipient of an MCRI Population Health Theme Funding Grant (2025).
Dr Grant's research is informed by lived experience of allergic disease, with the goal of understanding the factors that shape food allergy development in order to improve prevention and intervention strategies in early life. She serves as a peer mentor for Allergy250K, a support program run by the National Allergy Council, where she supports school-aged children and young people living with severe allergies. Dr Grant has also contributed as a lived experience advocate in national roundtable discussions on improving the transition of patients from paediatric to adult allergy care in Australia, and in the development of national guidelines for food allergy management in the food service sector.
Dr Rhiannon Grant is an early career postdoctoral researcher in the Population Allergy group at MCRI, where she investigates the development of food allergies in early life. She completed her PhD in immunology at Monash University in 2025, examining...
Dr Rhiannon Grant is an early career postdoctoral researcher in the Population Allergy group at MCRI, where she investigates the development of food allergies in early life. She completed her PhD in immunology at Monash University in 2025, examining the molecular mechanisms of an emerging therapy for allergic disease using in vitro models of asthma and atopic dermatitis.
Dr Grant's current research focuses on systemic changes across the first year of life in infants with food allergy within the Vitality Trial, with the aim of identifying predictive biomarkers of food allergy and potential targets for early intervention. She is the recipient of an MCRI Population Health Theme Funding Grant (2025).
Dr Grant's research is informed by lived experience of allergic disease, with the goal of understanding the factors that shape food allergy development in order to improve prevention and intervention strategies in early life. She serves as a peer mentor for Allergy250K, a support program run by the National Allergy Council, where she supports school-aged children and young people living with severe allergies. Dr Grant has also contributed as a lived experience advocate in national roundtable discussions on improving the transition of patients from paediatric to adult allergy care in Australia, and in the development of national guidelines for food allergy management in the food service sector.
Dr Grant's current research focuses on systemic changes across the first year of life in infants with food allergy within the Vitality Trial, with the aim of identifying predictive biomarkers of food allergy and potential targets for early intervention. She is the recipient of an MCRI Population Health Theme Funding Grant (2025).
Dr Grant's research is informed by lived experience of allergic disease, with the goal of understanding the factors that shape food allergy development in order to improve prevention and intervention strategies in early life. She serves as a peer mentor for Allergy250K, a support program run by the National Allergy Council, where she supports school-aged children and young people living with severe allergies. Dr Grant has also contributed as a lived experience advocate in national roundtable discussions on improving the transition of patients from paediatric to adult allergy care in Australia, and in the development of national guidelines for food allergy management in the food service sector.
Top Publications
- Perdijk, O, Butler, A, Macowan, M, Chatzis, R, Bulanda, E, Grant, RD, Harris, NL, Wypych, TP, Marsland, BJ. Antibiotic-driven dysbiosis in early life disrupts indole-3-propionic acid production and exacerbates allergic airway inflammation in adulthood.. Immunity 57(8) : 1939 -1954.e7 2024 view publication
- Chitty, JL, Yam, M, Perryman, L, Parker, AL, Skhinas, JN, Setargew, YFI, Mok, ETY, Tran, E, Grant, RD, Latham, SL, et al. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.. Nat Cancer 4(9) : 1326 -1344 2023 view publication
- Setargew, YFI, Wyllie, K, Grant, RD, Chitty, JL, Cox, TR. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours.. Cancers (Basel) 13(3) : 2021 view publication
- Chitty, JL, Skhinas, JN, Filipe, EC, Wang, S, Cupello, CR, Grant, RD, Yam, M, Papanicolaou, M, Major, G, Zaratzian, A, et al. The Mini-Organo: A rapid high-throughput 3D coculture organotypic assay for oncology screening and drug development.. Cancer Rep (Hoboken) 3(1) : e1209 2020 view publication
Career information
Share //
